Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
UnitedHealth Group kicks off earnings season for the health care sector Tuesday morning, and analysts are expecting double-digit sales and profit growth from the nation's largest health insurance and health care services firm.
UnitedHealth is expected to report fourth-quarter earnings of $3.21 per share, up 23 percent year over year, according to analyst consensus estimates from Refinitiv. Revenues are expected to top $58 billion, which would be 11.4 percent higher than a year ago. Following its third-quarter report, the company boosted its full-year 2018 earnings guidance to roughly $12.80 per share on revenues of $226 billion.
United's earnings beat analyst's expectations more than 90 percent of the time, according to Bespoke Investment Group, on average by 2.9 percent. The firm's revenues top estimates about two-thirds of the time by about 1 percent on average.
Nephron analyst Josh Raskin notes that health insurers, as a group, pulled back 18 percent from the end of last earnings season through the start of the new year, 6 points more than the overall S&P 500, making potential earnings beats for the group more compelling.
"We are certainly more bullish than we were just a month ago ... with the recent pullback we have not materially changed our estimates, nor targets and therefore expected returns are higher," he wrote in a note to clients looking ahead to earnings season.
United is forecasting continued double-digit full-year earnings and sales growth for 2019 of $14.40 to $14.70 per share on revenues of $243 billion to $245 billion.
On a valuation basis, UnitedHealth shares are trading at 19.5 times estimated forward earnings, which puts it at a premium to its health insurance peers. Centene has a forward price earnings ratio of 17, Anthem trades at 16 times estimated forward earnings.
Analysts will be watching for any news on UnitedHealth's acquisition strategy, which has been focused primarily on extending its Optum division's services portfolio. The firm is reportedly among the parties bidding for a possible acquisition of Tenet Healthcare's health care management subsidiary Conifer unit, according to the Wall Street Journal citing people familiar with the matter.
Optum's largest deals last year included the acquisition of pharmacy and health benefits firm Genoa Healthcare for $2.5 billion, and hospital staffing firm Sound Impatient Physician Holdings for $2.2 billion.
United was one of a handful of Dow components trading higher today, ahead of its earnings report which is due out Tuesday before the opening bell.
—By Bertha Coombs. Follow her on Twitter: @coombscnbc